-
Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx
Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx We are proud to have been chosen by PluriStyx […]
-
Webinar: Treating Blindness with Stem Cell Therapies
How close are we to one-shot stem cell therapies for eye disease? What are the critical factors for successful translation to the clinic? Join us for the panel discussion!
-
BioLamina AB appoints Klaus Langhoff-Roos as new CEO.
Stockholm August 15, 2024 BioLamina appoints Klaus Langhoff-Roos as new CEO. BioLamina AB, a leading maker of reagents for stem […]
-
Meet us at our next events!
Meet us at our next events Meet us to discuss how we can help you revolutionize cell culture. We will […]
-
BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite
Stockholm May 23rd, 2023 BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite BioLamina announces […]